Journal article

Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants

Pauline Verdijk, Nynke Y. Rots, Monique G. C. T. van Oijen, William C. Weldon, M. Steven Oberste, Hiromasa Okayasu, Roland W. Sutter, Wilfried A. M. Bakker

Safety and immunogenicity of Sabin-IPV (sIPV) was evaluated in a double-blind, randomized, controlled, dose-escalation trial in the target population. Healthy infants (n=20/group) aged 56-63 days, received a primary series of three intramuscular injections with low-, middle- or high-dose sIPV with or without aluminum hydroxide or with the conventional IPV based on wild poliovirus strains (wIPV). Virus-neutralizing titers against both Sabin and wild poliovirus strains were determined before and 28 days after three vaccinations.

Authors

Languages

  • English

Publication year

2014

Journal

Vaccine

Volume

9

Type

Journal article

Categories

  • Vaccines & delivery devices

Diseases

  • Polio

Tags

  • Vaccine trials

Added by: Moderator

Added on: 2015-11-21 10:37:01

Hits: 2261

Links

PubMED URL

http://www.ncbi.nlm.nih.gov/pubmed/25043278

Add resource